Balancing Cancer Immunotherapy Efficacy and Toxicity

Anti–programmed cell death-1 receptor/programmed cell death-1 receptor ligand–directed therapies are transforming cancer care, with durable antitumor responses observed in multiple cancer types. Toxicities arising from therapy are autoimmune in nature and may affect essentially any organ system. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Douglas B., Jakubovic, Baruch D., Sibaud, Vincent, Sise, Meghan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2020
Materias:
Review and Feature Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318967/
https://www.ncbi.nlm.nih.gov/pubmed/32599218
http://dx.doi.org/10.1016/j.jaip.2020.06.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318967/
https://www.ncbi.nlm.nih.gov/pubmed/32599218
http://dx.doi.org/10.1016/j.jaip.2020.06.028

Ejemplares similares